NEW YORK (AP) -- Shares of Biomira Inc. surged Wednesday after the Canadian biotech drugmaker said it is entitled to an undisclosed milestone payment from its partner, the German drug maker Merck KGaA, for beginning a late stage clinical trial for Stimuvax.
